Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 13 papers. Top paper: “A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations”.
Tyler Zemla, Joleen M. Hubbard, John H. Strickler, Olumide B. Gbolahan, L. R. Wilson +6 more
Mustafa Al Obaidi, Alice N. Weaver, Kelly Kenzik, Andrew M. McDonald, Mackenzi Pergolotti +6 more
Chen Dai, Mustafa Al Obaidi, Smith Giri, Kelly Kenzik, Andrew M. McDonald +6 more
Mustafa Al‐Obaidi, Christian Harmon, Chen Dai, Crystal Young Smith, Olumide B. Gbolahan +3 more
Mustafa Al‐Obaidi, Joseph E. Rower, Christian Harmon, Chen Dai, Edward P. Acosta +9 more
Brett Barlow, Mustafa Al‐Obaidi, Christian Harmon, Chen Dai, Mackenzi Pergolotti +4 more
Smith Giri, Nabiel Mir, Kelly Kenzik, Andrew M. McDonald, Crystal Young Smith +5 more
Nabiel Mir, Mustafa Al‐Obaidi, Deanna Clark, Kelly Kenzik, Andrew M. McDonald +10 more
Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more
Mackenzie E. Fowler, Christian Harmon, Mustafa Al‐Obaidi, Darryl Outlaw, Robert H. Hollis +5 more
Sarah Kosmicki, Christian Harmon, Darryl Outlaw, Olumide B. Gbolahan, Moh’d Khushman +4 more
Olatunji B. Alese, Natalie K. Horvat, Emily R. Greene, Olumide B. Gbolahan, Kathleen Coleman +11 more
Chen Dai, Carson Foster, Mustafa Al‐Obaidi, Christian Harmon, Kirsten A. Nyrop +4 more